Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Transfusion science

Showing results (381-390 of 545) with videos related to

Pageof 55
Sort By:
Transfusion Science|April 20, 2000
Laboratory and clinical aspects of platelet concentratesSeghatchian
Transfusion Science|April 20, 2000
Platelet products, where to?J K Duguid, A C Newland
Transfusion Science|April 20, 2000
EditorialHamblin
Transfusion Science|April 20, 2000
Factors influencing the outcome of leucodepletion systemJ Seghatchian, P Krailadsiri
Transfusion Science|December 2, 2000
The importance of non-transferrin bound iron in disorders of iron metabolismW Breuer, C Hershko, Z I Cabantchik
Transfusion Science|December 2, 2000
Clinical aspects of hemochromatosisP Brissot, D Guyader, O Loréal, et al.
Transfusion Science|December 2, 2000
Desferrioxamine-chelatable iron (DCI), a component of serum non-transferrin-bound iron (NTBI) used for assessing iron chelation therapyW Breuer, M J Ermers, P Pootrakul, et al.
Transfusion Science|December 2, 2000
Non-transferrin-bound iron, iron-related oxidative stress and lipid peroxidation in beta-thalassemia intermediaM Domenica Cappellini, D Tavazzi, L Duca, et al.
Transfusion Science|December 2, 2000
Combining iron chelators with the nucleoside analog didanosine in anti-HIV therapyN A Georgiou, T van der Bruggen, M Oudshoorn, et al.
Transfusion Science|December 2, 2000
Endocrine problems in ex-thalassemic patientsA C Kattamis, M Antoniadis, I Manoli, et al.
Pageof 55

Showing results (381-390 of 545) with videos related to

Sort By:
Pageof 55
Transfusion Science|April 20, 2000
Laboratory and clinical aspects of platelet concentratesSeghatchian
Transfusion Science|April 20, 2000
Platelet products, where to?J K Duguid, A C Newland
Transfusion Science|April 20, 2000
EditorialHamblin
Transfusion Science|April 20, 2000
Factors influencing the outcome of leucodepletion systemJ Seghatchian, P Krailadsiri
Transfusion Science|December 2, 2000
The importance of non-transferrin bound iron in disorders of iron metabolismW Breuer, C Hershko, Z I Cabantchik
Transfusion Science|December 2, 2000
Clinical aspects of hemochromatosisP Brissot, D Guyader, O Loréal, et al.
Transfusion Science|December 2, 2000
Desferrioxamine-chelatable iron (DCI), a component of serum non-transferrin-bound iron (NTBI) used for assessing iron chelation therapyW Breuer, M J Ermers, P Pootrakul, et al.
Transfusion Science|December 2, 2000
Non-transferrin-bound iron, iron-related oxidative stress and lipid peroxidation in beta-thalassemia intermediaM Domenica Cappellini, D Tavazzi, L Duca, et al.
Transfusion Science|December 2, 2000
Combining iron chelators with the nucleoside analog didanosine in anti-HIV therapyN A Georgiou, T van der Bruggen, M Oudshoorn, et al.
Transfusion Science|December 2, 2000
Endocrine problems in ex-thalassemic patientsA C Kattamis, M Antoniadis, I Manoli, et al.
Pageof 55